Catalyst
Slingshot members are tracking this event:
Ionis Pharmaceuticals (IONS) to submit application for Volanesorsen, which treats patients with familial chylomicronemia syndrome (FCS), to EU EMA in Q3 of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IONS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 27, 2017
Occurred Source:
http://ir.ionispharma.com/phoenix.zhtml?c=222170&p=irol-newsArticle&ID=2289319
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Volanesorsen, European Medicines Agency, Fcs
